MONTREAL, CANADA, March 16, 2007 – Technologie Biolactis, Inc., a Canadian biotechnology company specializing in the development of lactoceuticals focused on cardiovascular, metabolism and obesity-associated disorders, is pleased to announce the appointment of Professor Achim Kaufhold, M.D., to its Board of Directors.
